Combinational therapeutics to combat cancer

Mono-therapeutics is rarely effective as a treatment option, which limits the survival of patients in advanced grade aggressive cancers. Combinational therapeutics (multiple drugs for multiple targets) to combat cancer is gaining momentum in recent years. Hence, it is of interest to document known d...

Descripción completa

Detalles Bibliográficos
Autores principales: Otaibi, Ahmed Al, Sherwani, Subuhi, Alshammari, Eida Mohammed, Al-Zahrani, Salma Ahmed, Khan, Wahid Ali, Dhahi Alsukaibi, Abdulmohsen Khalaf, Dwivedi, Sourabh, Khan, Shahper Nazeer, Khan, Mohd Wajid Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Biomedical Informatics 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882074/
https://www.ncbi.nlm.nih.gov/pubmed/35283582
http://dx.doi.org/10.6026/97320630017673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882074/
https://www.ncbi.nlm.nih.gov/pubmed/35283582
http://dx.doi.org/10.6026/97320630017673

Ejemplares similares